This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Richter Gedeon Vegyeszeti Gyar Rt. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Exploring the Innovations of Ferencné Kassai in the Field of Cabergoline Preparation
Introduction
Ferencné Kassai, an innovative inventor based in Budapest, Hungary, has made a significant contribution to the pharmaceutical industry with his patent on a process for the preparation of cabergoline. His work demonstrates the intersection of chemistry and medicinal applications, showcasing his expertise in the field.
Latest Patents
Kassai holds one patent titled "Process for the Preparation of Cabergoline." This patent details a method for preparing cabergoline from ergoline-8β-carboxylic acid ester. The process includes several critical steps involving various intermediates and highlights the production of the polymorphic amorphous form of cabergoline. This invention plays an essential role in advancing the availability of cabergoline, a medication used in treating conditions such as hyperprolactinemia.
Career Highlights
Throughout his career, Kassai has been involved in groundbreaking research at Richter Gedeon Vegyeszeti Gyar Rt, a leading pharmaceutical company. His dedication to innovation has not only resulted in important advancements in drug preparation but also solidified his status as a respected inventor within the scientific community.
Collaborations
Ferencné Kassai has collaborated with notable coworkers such as Janos Galambos and Laszlo Czibula. Together, they have worked to push the boundaries of pharmaceutical research and development, contributing to the successful innovation of several projects in their field.
Conclusion
In summary, Ferencné Kassai's contributions to the preparation of cabergoline exemplify the vital role of inventors in the medical science industry. His patent reflects a commitment to improving pharmaceuticals, particularly through the innovative techniques developed at Richter Gedeon Vegyeszeti Gyar Rt. As he continues to collaborate with his colleagues, the impact of his work will likely resonate throughout the industry for years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
